J. M. Morris

Learn More
In 2003, the FIP Dissolution Working group published a position paper on dissolution/drug release testing for special/novel dosage forms that represented the scientific opinions of many experts in the field at that time (1). The position paper has supported activities, programs, and decisions in the scientific, technical, and regulatory community. Due to(More)
Taking action to protect patients from impaired colleagues is a long-standing ethical and professional obligation. In 2010, this responsibility was codified in law with the introduction, across Australia, of a new mandatory reporting regimen. While several concerns remain to be addressed, mandatory reporting has the potential not only to reinforce the(More)
Fly-in/Fly-out models of health care for rural-remote communities are currently the focus of evaluation and debate, as the health inequalities of rural and remote communities continue to challenge both health service providers and healthcare consumers. At first glance, these models of health care may attract new graduate nurses transitioning to practice,(More)
In 2003, the FIP Dissolution Working group published a position paper on dissolution/drug release testing for special/novel dosage forms that represented the scientific opinions of many experts in the field at that time (1). The position paper has supported activities, programs, and decisions in the scientific, technical, and regulatory community. Due to(More)
A series of serial passages of Triticum mosaic virus (TriMV) was performed in winter wheat under greenhouse conditions to examine the dynamics of sequence variation in the TriMV population. The variation within the protein 1 (P1) and the coat protein (CP) of TriMV was assessed by single-strand conformational polymorphism (SSCP) assay, followed by nucleotide(More)
Biorelevant in vitro performance testing of orally administered dosage forms has become an important tool for the assessment of drug product in vivo behavior. An in vitro performance test which mimics the intraluminal performance of an oral dosage form is termed biorelevant. Biorelevant tests have been utilized to decrease the number of in vivo studies(More)
Previous workers in the lab created an infectious clone of Wheat Streak Mosaic Virus (WSMV) designated S1RN. An additional infectious clone with a GUS insert was also created to permit easy observation of virus movement (Gus1RN). A single point mutation made within the HC-Pro region created a mutant of WSMV designated PS81 that was unable to cause a(More)